Related Experiment Video
Updated: Sep 22, 2025

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
Maximum Entropy Technique and Regularization Functional for Determining the Pharmacokinetic Parameters in DCE-MRI.
Zahra Amini Farsani1,2, Volker J Schmid3
1Bayesian Imaging and Spatial Statistics Group, Institute of Statistics, Ludwig-Maximilian-Universität München, Ludwigstraße 33, 80539, Munich, Germany. zahra.farsani@stat.uni-muenchen.de.
This study presents a new algorithm for determining the arterial input function (AIF) in dynamic contrast-enhanced MRI (DCE-MRI) using maximum entropy and Bayesian methods. The approach improves accuracy and robustness for pharmacokinetic analysis in medical imaging.
Area of Science:
- Medical Imaging
- Biophysics
- Computational Science
Background:
- Accurate determination of the arterial input function (AIF) is crucial for pharmacokinetic analysis in dynamic contrast-enhanced MRI (DCE-MRI).
- The AIF estimation is a challenging linear ill-posed inverse problem, often leading to ill-conditioned systems of equations after discretization.
- Existing methods may lack robustness or require complex optimization techniques.
Purpose of the Study:
- To develop and validate a novel algorithm for robust AIF determination in DCE-MRI.
- To improve the estimation of pharmacokinetic parameters by enhancing AIF accuracy.
- To address the ill-posed nature of AIF estimation using maximum entropy and Bayesian inference.
Main Methods:
- Utilized the maximum entropy technique (MET) combined with regularization functionals.
- Employed a Bayesian estimation approach to infer pharmacokinetic parameters and quantify solution uncertainties.
- Developed a new algorithm to estimate probability distribution functions for the AIF, specifically exploring Gamma and Erlang distributions.
Main Results:
- The proposed algorithm demonstrated improved convergence behavior and more consistent results compared to previous methods (e.g., exponential or Weibull distributions).
- Analysis of simulated and real breast tumor datasets showed enhanced morphological and functional statistics.
- The Gamma and Erlang distributions, estimated by the new algorithm, proved to be more appropriate and robust AIFs.
Conclusions:
- The novel algorithm effectively solves the AIF determination problem in DCE-MRI, offering a more robust and accurate solution.
- Combining Bayesian inference with maximum entropy regularization enhances the reliability of pharmacokinetic parameter estimation.
- This approach provides a significant advancement for quantitative analysis in DCE-MRI studies, particularly for tumor characterization.
More Related Videos
08:59Use of a Multi-compartment Dynamic Single Enzyme Phantom for Studies of Hyperpolarized Magnetic Resonance Agents
Published on: April 15, 2016
15:10A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat
Published on: December 28, 2013
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis of Population Pharmacokinetic Data
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...